Expand PTHS Menu
PTHS MENU

PTHS Latest Press Releases

-- February 23, 2026 --

Pelthos Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference Globe Newswire 8:00 AM

-- January 15, 2026 --

Horizon Technology Finance Provides up to $50 Million Venture Loan Facility to Pelthos Therapeutics Business Wire 4:10 PM

-- January 13, 2026 --

Pelthos Therapeutics Secures Up to $50 Million Senior Secured Term Loan Facility from Horizon Technology Finance Globe Newswire 8:30 AM

-- January 5, 2026 --

Pelthos Therapeutics Acquires Xeglyze (abametapir) Topical Treatment for Head Lice Globe Newswire 7:30 AM

-- December 23, 2025 --

Pelthos Therapeutics Expands Board of Directors with the Appointment of Andrew Einhorn Globe Newswire 5:57 PM

-- December 4, 2025 --

Pelthos Therapeutics Signs Major Pharmacy Benefit Manager Agreement Expanding Patient Access to ZELSUVMI (berdazimer) Topical Gel, 10.3% Globe Newswire 7:00 AM

-- December 2, 2025 --

Pelthos Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference Globe Newswire 8:00 AM

-- November 13, 2025 --

Pelthos Therapeutics Announces Third Quarter Fiscal 2025 Financial Results Globe Newswire 6:45 AM

-- November 7, 2025 --

Pelthos Therapeutics Acquires Xepi (ozenoxacin) Cream, 1% and Announces $18 Million Private Convertible Notes Financing Globe Newswire 8:00 AM

-- November 5, 2025 --

Pelthos Therapeutics to Report Third Quarter 2025 Financial Results on November 13, 2025 Globe Newswire 8:00 AM

-- October 9, 2025 --

Pelthos Therapeutics Launches Moms Against Molluscum Movement to Unite Families Affected by Molluscum Contagiosum Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes